Angiotensin Receptor Blockade and Risk of Cancer in Type 2 Diabetes Mellitus: A Nationwide Case-Control Study
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiotensin Receptor Blockade and Risk of Cancer in Type 2 Diabetes Mellitus: A Nationwide Case-Control Study
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 29, Issue 22, Pages 3001-3007
Publisher
American Society of Clinical Oncology (ASCO)
Online
2011-06-21
DOI
10.1200/jco.2011.35.1908
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals
- (2016) JOURNAL OF HYPERTENSION
- Angiotensin II Receptor Blockers and Risk of Cancer in Patients With Systemic Hypertension
- (2011) Chin-Chou Huang et al. AMERICAN JOURNAL OF CARDIOLOGY
- Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
- (2011) Hermann Haller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region
- (2010) E. K. K. Lam et al. ANNALS OF ONCOLOGY
- Diabetes and Cancer: A Consensus Report
- (2010) E. Giovannucci et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pleiotropic Effects of Inhibitors of the RAAS in the Diabetic Population: Above and Beyond Blood Pressure Lowering
- (2010) Haisam Ismail et al. Current Diabetes Reports
- Diabetes, prediabetes and cancer mortality
- (2010) X. H. Zhou et al. DIABETOLOGIA
- Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure
- (2010) S. L. Bowker et al. DIABETOLOGIA
- Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway
- (2010) Yanbin Zhao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Angiotensin-receptor blockers and cancer: urgent regulatory review needed
- (2010) Steven E Nissen LANCET ONCOLOGY
- Angiotensin-receptor blockade, cancer, and concerns
- (2010) Stevo Julius et al. LANCET ONCOLOGY
- Angiotensin-receptor blockade, cancer, and concerns
- (2010) Mark R Goldstein et al. LANCET ONCOLOGY
- Angiotensin-receptor blockade, cancer, and concerns
- (2010) Peter A Meredith et al. LANCET ONCOLOGY
- Angiotensin-receptor blockade, cancer, and concerns
- (2010) Vivencio Barrios et al. LANCET ONCOLOGY
- Angiotensin-receptor blockade, cancer, and concerns
- (2010) Michael Böhm et al. LANCET ONCOLOGY
- Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials
- (2010) Ilke Sipahi et al. LANCET ONCOLOGY
- Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials
- (2010) Sripal Bangalore et al. LANCET ONCOLOGY
- Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma
- (2009) Andréia Hanada Otake et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Evaluation of a hepatitis B vaccination program in Taiwan: impact on hepatocellular carcinoma development
- (2009) Isabelle Chemin Future Oncology
- Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan
- (2008) Chi–Ling Chen et al. GASTROENTEROLOGY
- Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: A new role in the treatment of leukaemia for these agents
- (2008) Silvia De la Iglesia Iñigo et al. LEUKEMIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More